12a. Epidemiology by country – an overview Archives

Chapter 12c: Risk Map for TBEV

In the map below, the areas highlighted in orange indicate TBEV endemic regions as documented either by 1) TBEV detection in ticks or animals; or 2) detection of specific anti-TBE antibodies in reservoir animals or human sera; or 3) microbiologically confirmed locally acquired TBE cases in humans who contracted the disease in the respective region. This map does not reflect the incidence of the disease or the prevalence of the virus in a given area... >>> view map... Read More...

Chapter 12b: Epidemiology by country – country data

While TBE is listed as a “communicable disease” in the EU since 2012, each country implements reporting nationally with own resources and methods. In most instances, reporting of TBE cases is based on passive surveillance and thus largely depend on disease awareness with physicians and on availability, cost and use of serological tests for TBE diagnosis. Systematic, regular use of TBE serology in the appropriate clinical setting is in place in few countries only, despite the fact that it would be a necessary prerequisite to gain... >>> read more

Chapter 12a: Epidemiology by country – an overview

TBE is a flavivirus infection of the central nervous system (CNS), transmitted by ticks and in some rare instances by ingestion of unpasteurized milk.
TBE is diagnosed in the forested belts of Northern Eurasia ranging from eastern France and Norway down to northern Italy through central and Eastern Europe, Russia, Kazakhstan, and China to the northern Japanese island of Hokkaido.
About 10,000 cases of TBE are reported annually... >>> read more